Stuart Bloom has been a consultant gastroenterologist at UCLH since 1996. Stuart studied medicine at Oxford and St Thomas and trained in general Medicine and gastroenterology in Oxford and Liverpool. He was previously MRC training fellow at the Institute of Molecular Medicine, Oxford, and was awarded his doctorate for work on adhesion molecules in the gastrointestinal tract. He was clinical director of gastroenterology at UCLH from 2001-2006 and has been chair of the inflammatory bowel disease section of the British Society of Gastroenterology since 2006. He is currently chair of the consultants committee at UCLH. In March 2008 he was appointed GI specialty lead for the central and east london comprehensive research network and in August 2008 he was appointed national GI specialty lead to the UK clincial research network. His key clinical interests are in the the care of patients with inflammatory bowel disease and irritable bowel syndrome.
Briskin M, Winsor-Hynes D, Shyjan A, Bloom S, Wilson J, McEvoy L, Butcher EC, Kassam N, Mackay CR, Newman W, Ringler DJ. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. American Journal of Pathology 1997;151(1):97-110.
Harbord M, Hankin A, Bloom S, Mitchison H. Association between p47phox pseudogenes and inflammatory bowel disease. Blood 2003;101:3337
Basset C, Holton J, Bazeos A, Vaira D, Bloom S. Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Digestive Diseases and Sciences 2004;49(9):1425-32
Bloom S, Kiilerich S, Lassen MR, Forbes A, Leiper K, Langholz E, Irvine EJ, O’Morain C, Lowson D, Orm S. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Alimentary Pharmacology & Therapeutics 2004;19(8):871-878
Dhar A, Johnson KS, Novelli MR, Bown SG, Bigio IJ, Lovat LB, Bloom SL. Elastic scattering spectroscopy for the diagnosis of colonic lesions: initial results of a novel optical biopsy technique.
Gastrointestinal Endoscopy 2006;63:257-61
Marks DJB, Harbord MWN, MacAllister R, Rahman FZ, Young J, Al-Lazikani B, Lees W, Novelli M, Bloom S, Segal AW. Defective acute inflammation in Crohn’s disease: a clinical investigation. Lancet 2006;367:668678
Harbord MWN, Marks DJB, Forbes A, Bloom SL, Day RM, Segal AW. Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte-colony stimulating factor. Alimentary Pharmacology & Therapeutics 2006;24:651660
Marks DJB, Rahman FZ, Novelli M, Yu RC, McCartney S, Bloom S, Segal AW. An exuberant inflammatory response to E coli: implications for the pathogenesis of ulcerative colitis and pyoderma gangrenosum. Gut 2006;55:1662-1663
Rahman FZ, Marks DJ, Hayee BH, Smith AM, Bloom SL, Segal AW. Phagocyte dysfunction and inflammatory bowel disease. Inflammatory Bowel Disease 2008 Apr 17 [Epub ahead of print]